TWD
NVCR icon

True Wealth Design’s NovoCure NVCR Stock Holding History

True Wealth Design’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.4K Sell
821
-315
-28% -$4.77K ﹤0.01% 986
2026
Q1 		$12.4K Sell
1,136
-381
-25% -$4.76K ﹤0.01% 904
2025
Q4 		$19.6K Buy
1,517
+579
+62% +$7.43K 0.01% 614
2025
Q3 		$12.1K Buy
938
+506
+117% +$6.76K ﹤0.01% 766
2025
Q2 		$7.69K Buy
432
+55
+15% +$958 ﹤0.01% 669
2025
Q1 		$6.72K Buy
377
+262
+228% +$5.95K ﹤0.01% 589
2024
Q4 		$3.43K Buy
+115
New +$2.43K ﹤0.01% 613
2023
Q3 		– Sell
-1
Closed -$42 – 802
2023
Q2 		$42 Hold
1
– – ﹤0.01% 766
2023
Q1 		$61 Hold
1
– – ﹤0.01% 827
2022
Q4 		$73 Buy
+1
New +$75 ﹤0.01% 757

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

True Wealth Design's NVCR Position: Q2 2026 in Review

True Wealth Design reduced its NovoCure (NVCR) stake by 28% in Q2 2026, selling an estimated $4.77K and leaving 821 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #986.

True Wealth Design first reported a position in NVCR in Q4 2022 and has held it in 10 quarters since. The position peaked at $19.6K in Q4 2025. 216 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • True Wealth Design held 821 shares of NovoCure worth $12.4K as of Q2 2026.
  • True Wealth Design sold 315 NovoCure shares in Q2 2026, an estimated $4.77K.
  • NovoCure made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #986 holding.
  • True Wealth Design first reported a position in NovoCure in Q4 2022 and has held it in 10 quarters since.
  • True Wealth Design's NovoCure position peaked at $19.6K in Q4 2025.
  • 216 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.